A woman has filed a lawsuit against Novo Nordisk, the manufacturer of the popular diabetes drugs marketed under the the brand names Ozempic and Wegovy, claiming that the drug’s labeling doesn’t adequently warn about the potential side effects. One of those side effects, Juanita Gantt claimed on CBS Mornings, impacted her colon, which she asserts had to be removed as a result of the medication. Novo Nordisk has responded to the claims, saying the suit is "without merit." Gantt says she was first prescribed Wegovy, and then Ozempic, because her doctor thought she was at risk of developing diabetes. As...